InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Victoria Hull. Director active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 3 reports have been recorded. Activity tracked since 8 April 2025. The latest transaction was disclosed on 27 April 2026 (Purchase). Regulator: RNS (LSE). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations